Jeremy Manry

10PUBLICATIONS
269CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)MechanobiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 16, 2022
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.

Qian Zhang, Andrés Pizzorno, Lisa Miorin

|Jul 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.

Paul Bastard, Sara E Vazquez, Jamin Liu

|Jan 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.

Jeremy Manry, Paul Bastard, Adrian Gervais

|Nov 02, 2021
Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis.

Jie Chen, Huie Jing, Andrea Martin-Nalda

|Dec 18, 2020
Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology.

M Foulon, M Robbe-Saule, J Manry

|Sep 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Paul Bastard, Lindsey B Rosen, Qian Zhang

Pageof 2

Frequent Collaborators

6 joint publications

Laurent Abel

5 joint publications

Aurélie Cobat

5 joint publications

Paul Bastard

5 joint publications

Jean-Laurent Casanova